CN100453098C - 一种治疗慢性肾功能不全的药物及其制备方法 - Google Patents
一种治疗慢性肾功能不全的药物及其制备方法 Download PDFInfo
- Publication number
- CN100453098C CN100453098C CNB2005100694884A CN200510069488A CN100453098C CN 100453098 C CN100453098 C CN 100453098C CN B2005100694884 A CNB2005100694884 A CN B2005100694884A CN 200510069488 A CN200510069488 A CN 200510069488A CN 100453098 C CN100453098 C CN 100453098C
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- medicine
- salviae miltiorrhizae
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 134
- 208000020832 chronic kidney disease Diseases 0.000 title claims abstract description 31
- 229940079593 drug Drugs 0.000 title claims description 17
- 238000000034 method Methods 0.000 title abstract description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 109
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 19
- 241000123069 Ocyurus chrysurus Species 0.000 claims abstract description 18
- 235000008282 Sanguisorba officinalis Nutrition 0.000 claims abstract description 18
- 239000002994 raw material Substances 0.000 claims abstract description 16
- 238000002360 preparation method Methods 0.000 claims abstract description 9
- 238000010992 reflux Methods 0.000 claims abstract description 9
- 241000545442 Radix Species 0.000 claims description 34
- 239000007788 liquid Substances 0.000 claims description 34
- 239000003921 oil Substances 0.000 claims description 25
- 241000628997 Flos Species 0.000 claims description 19
- 241000581682 Sanguisorba Species 0.000 claims description 17
- 241001180876 Saposhnikovia Species 0.000 claims description 17
- 238000002156 mixing Methods 0.000 claims description 17
- -1 filters Substances 0.000 claims description 13
- 239000000706 filtrate Substances 0.000 claims description 13
- 239000008187 granular material Substances 0.000 claims description 13
- 239000006228 supernatant Substances 0.000 claims description 13
- 239000012567 medical material Substances 0.000 claims description 12
- 239000000341 volatile oil Substances 0.000 claims description 12
- 239000000796 flavoring agent Substances 0.000 claims description 11
- 235000019634 flavors Nutrition 0.000 claims description 11
- 238000003756 stirring Methods 0.000 claims description 11
- 239000003795 chemical substances by application Substances 0.000 claims description 9
- 239000012141 concentrate Substances 0.000 claims description 8
- 238000004821 distillation Methods 0.000 claims description 8
- 238000004064 recycling Methods 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 7
- 229920001353 Dextrin Polymers 0.000 claims description 6
- 239000004375 Dextrin Substances 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 6
- 235000019425 dextrin Nutrition 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 238000001556 precipitation Methods 0.000 claims description 6
- 238000001291 vacuum drying Methods 0.000 claims description 6
- 229920000858 Cyclodextrin Polymers 0.000 claims description 5
- 239000001116 FEMA 4028 Substances 0.000 claims description 5
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 5
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims description 5
- 229960004853 betadex Drugs 0.000 claims description 5
- 239000004411 aluminium Substances 0.000 claims description 4
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 4
- 229910052782 aluminium Inorganic materials 0.000 claims description 4
- 239000000284 extract Substances 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 4
- 238000005469 granulation Methods 0.000 claims description 4
- 230000003179 granulation Effects 0.000 claims description 4
- 239000012528 membrane Substances 0.000 claims description 4
- 238000012856 packing Methods 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 4
- 238000004659 sterilization and disinfection Methods 0.000 claims description 4
- 229930189533 tanshinol Natural products 0.000 claims description 4
- 239000009636 Huang Qi Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 44
- 229940126678 chinese medicines Drugs 0.000 abstract 3
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241000123589 Dipsacus Species 0.000 abstract 1
- 241000208688 Eucommia Species 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 241000229179 Ledebouriella Species 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 240000004064 Poterium sanguisorba Species 0.000 abstract 1
- 235000008291 Poterium sanguisorba Nutrition 0.000 abstract 1
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 241000951473 Schizonepeta Species 0.000 abstract 1
- 241000219784 Sophora Species 0.000 abstract 1
- 241000316342 Taxillus Species 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 238000009835 boiling Methods 0.000 abstract 1
- 238000000151 deposition Methods 0.000 abstract 1
- 235000005412 red sage Nutrition 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 description 40
- 210000002700 urine Anatomy 0.000 description 37
- 241000700159 Rattus Species 0.000 description 30
- 210000004369 blood Anatomy 0.000 description 22
- 239000008280 blood Substances 0.000 description 22
- 241001465754 Metazoa Species 0.000 description 20
- 208000037157 Azotemia Diseases 0.000 description 19
- 230000001225 therapeutic effect Effects 0.000 description 18
- 241000283973 Oryctolagus cuniculus Species 0.000 description 15
- 230000037396 body weight Effects 0.000 description 14
- 206010020880 Hypertrophy Diseases 0.000 description 13
- 230000005484 gravity Effects 0.000 description 13
- 201000008383 nephritis Diseases 0.000 description 13
- 102000001554 Hemoglobins Human genes 0.000 description 10
- 108010054147 Hemoglobins Proteins 0.000 description 10
- 230000003907 kidney function Effects 0.000 description 10
- 230000009467 reduction Effects 0.000 description 10
- 206010001580 Albuminuria Diseases 0.000 description 9
- 206010058116 Nephrogenic anaemia Diseases 0.000 description 9
- 206010016654 Fibrosis Diseases 0.000 description 8
- 210000003743 erythrocyte Anatomy 0.000 description 8
- 230000004761 fibrosis Effects 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 206010038464 renal hypertension Diseases 0.000 description 8
- 210000002966 serum Anatomy 0.000 description 8
- 108010088751 Albumins Proteins 0.000 description 7
- 102000009027 Albumins Human genes 0.000 description 7
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 7
- 238000002651 drug therapy Methods 0.000 description 7
- 201000008350 membranous glomerulonephritis Diseases 0.000 description 7
- 231100000915 pathological change Toxicity 0.000 description 7
- 230000036285 pathological change Effects 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 206010021703 Indifference Diseases 0.000 description 6
- 208000001647 Renal Insufficiency Diseases 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 230000001447 compensatory effect Effects 0.000 description 6
- 201000006370 kidney failure Diseases 0.000 description 6
- 230000001575 pathological effect Effects 0.000 description 6
- 208000034767 Hypoproteinaemia Diseases 0.000 description 5
- 208000007502 anemia Diseases 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- 238000011552 rat model Methods 0.000 description 5
- 230000000630 rising effect Effects 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 5
- 210000005239 tubule Anatomy 0.000 description 5
- 238000005303 weighing Methods 0.000 description 5
- 235000019786 weight gain Nutrition 0.000 description 5
- 206010003694 Atrophy Diseases 0.000 description 4
- 230000037444 atrophy Effects 0.000 description 4
- 230000006837 decompression Effects 0.000 description 4
- 238000004043 dyeing Methods 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 3
- 208000034777 Vitreous degeneration Diseases 0.000 description 3
- 230000004872 arterial blood pressure Effects 0.000 description 3
- 238000004820 blood count Methods 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 238000009534 blood test Methods 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 230000037406 food intake Effects 0.000 description 3
- 230000008595 infiltration Effects 0.000 description 3
- 238000001764 infiltration Methods 0.000 description 3
- 210000000265 leukocyte Anatomy 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000003014 reinforcing effect Effects 0.000 description 3
- 201000002793 renal fibrosis Diseases 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 201000011288 vitreous syneresis Diseases 0.000 description 3
- 208000031816 Pathologic Dilatation Diseases 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 210000000436 anus Anatomy 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 201000005577 familial hyperlipidemia Diseases 0.000 description 2
- 230000001077 hypotensive effect Effects 0.000 description 2
- 238000002386 leaching Methods 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 206010003591 Ataxia Diseases 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 208000022831 chronic renal failure syndrome Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000001650 focal adhesion Anatomy 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000001631 haemodialysis Methods 0.000 description 1
- 230000000322 hemodialysis Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 201000010260 leiomyoma Diseases 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000001936 parietal effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000008807 pathological lesion Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 238000011555 rabbit model Methods 0.000 description 1
- 210000005084 renal tissue Anatomy 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100694884A CN100453098C (zh) | 2005-05-12 | 2005-05-12 | 一种治疗慢性肾功能不全的药物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100694884A CN100453098C (zh) | 2005-05-12 | 2005-05-12 | 一种治疗慢性肾功能不全的药物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1861124A CN1861124A (zh) | 2006-11-15 |
CN100453098C true CN100453098C (zh) | 2009-01-21 |
Family
ID=37388710
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100694884A Active CN100453098C (zh) | 2005-05-12 | 2005-05-12 | 一种治疗慢性肾功能不全的药物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100453098C (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104491581A (zh) * | 2014-12-29 | 2015-04-08 | 李淑秀 | 一种灌肠治疗慢性肾功能衰竭的药液 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1480195A (zh) * | 2003-06-09 | 2004-03-10 | 海南天元制药厂 | 治疗肾功能衰竭注射剂和栓剂的中药配方及其制备方法 |
-
2005
- 2005-05-12 CN CNB2005100694884A patent/CN100453098C/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1480195A (zh) * | 2003-06-09 | 2004-03-10 | 海南天元制药厂 | 治疗肾功能衰竭注射剂和栓剂的中药配方及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1861124A (zh) | 2006-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102755594B (zh) | 一种治疗急慢性乙肝的中药组合物及其制备方法 | |
CN101357219B (zh) | 一种用于治疗慢性乙型肝炎的药物 | |
CN1403149A (zh) | 一种治疗慢性心衰的药物组合物及制备方法 | |
CN104815166B (zh) | 一种治疗糖尿病的中药组合物及其制备和应用 | |
CN107693571B (zh) | 预防或治疗肝纤维化肝硬化的中药组合物、制剂及制剂的制备方法 | |
CN101849987B (zh) | 当归黄芪合剂醇提物与水提物制备及干预肺纤维化的应用 | |
CN104623196A (zh) | 一种用于治疗慢性肾炎的中药组合物及其制备方法和应用 | |
CN100522230C (zh) | 一种治疗糖尿病肾病的药物及其制备方法 | |
CN100518809C (zh) | 一种治疗糖尿病肾病的药物组合及其制备方法 | |
CN100453098C (zh) | 一种治疗慢性肾功能不全的药物及其制备方法 | |
CN106074810A (zh) | 一种三妙胶囊及其制备方法 | |
CN103638389A (zh) | 一种治疗糖尿病的中药组合物 | |
CN103948754B (zh) | 一种用于治疗肾虚湿热型慢性肾炎的药物及其制备方法 | |
CN100594921C (zh) | 一种治疗慢性乙型肝炎及肝硬化的中药复方制剂 | |
CN114306447A (zh) | 一种治疗肝癌的中药组合物及其应用 | |
CN103211961A (zh) | 一种治疗慢性肾功能不全的中药组合物 | |
CN1247229C (zh) | 一种中药组合物在制备改善肾纤维化的中药制剂中的应用 | |
CN1319578C (zh) | 一种中药组合物及其制备方法和用途 | |
CN101152467B (zh) | 一种用于治疗急慢性肝炎的中药制剂 | |
CN103893621A (zh) | 一种用于治疗老年性阴道炎的中药 | |
CN1720934A (zh) | 一种治疗前列腺增生症的药物及制备方法 | |
CN104173681B (zh) | 一种治疗去势抵抗性前列腺癌的中草药组合物 | |
CN102526470B (zh) | 一种治疗原发性高血压的药物组合物 | |
CN101987188A (zh) | 一种用于预防和治疗高血脂症的生物中成药 | |
CN1231247C (zh) | 一种用于孕妇安胎,节育安环的药物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: YABAO BEIZHONGDA (BEIJING) PHARMACEUTICAL CO., LTD Free format text: FORMER NAME: BEIJING UNIVERSITY OF CHINESE MEDICINE PHARMACEUTICAL FACTORY |
|
CP01 | Change in the name or title of a patent holder |
Address after: 101300, Lin River Street, 24 Industrial Development Zone, Shunyi District, Beijing Patentee after: In the North Asia (Beijing) Pharmaceutical Co. Ltd. Address before: 101300, Lin River Street, 24 Industrial Development Zone, Shunyi District, Beijing Patentee before: Pharmaceutical Factory of Beijing University of Chinese Medicine |
|
ASS | Succession or assignment of patent right |
Owner name: SHANXI YABAO PHARMACEUTICAL GROUP CORP. Free format text: FORMER OWNER: YABAO BEIZHONGDA (BEIJING) PHARMACEUTICAL CO., LTD. Effective date: 20141010 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 101300 SHUNYI, BEIJING TO: 044600 YUNCHENG, SHAANXI PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20141010 Address after: 044600 Fumin Road, Ruicheng County, Shanxi, China, No. 43, No. Patentee after: Shanxi Yabao Pharmaceutical Group Corp. Address before: 101300, Lin River Street, 24 Industrial Development Zone, Shunyi District, Beijing Patentee before: In the North Asia (Beijing) Pharmaceutical Co. Ltd. |
|
DD01 | Delivery of document by public notice |
Addressee: Qiao Shuzhen Document name: Notification of Passing Examination on Formalities |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180411 Address after: 101300 24 Linhe street, Linke Industrial Development Zone, Shunyi District, Beijing. Patentee after: In the North Asia (Beijing) Pharmaceutical Co. Ltd. Address before: 044600 Fumin Road, Ruicheng County, Shanxi, China, No. 43, No. Patentee before: Shanxi Yabao Pharmaceutical Group Corp. |
|
CP02 | Change in the address of a patent holder |
Address after: 101300 24 Lin He street, Linhe Industrial Development Zone, Shunyi District, Beijing Patentee after: In the North Asia (Beijing) Pharmaceutical Co. Ltd. Address before: 101300 24 Linhe street, Linke Industrial Development Zone, Shunyi District, Beijing. Patentee before: In the North Asia (Beijing) Pharmaceutical Co. Ltd. |
|
CP02 | Change in the address of a patent holder |